未登录

M

M. Helena García

universite lyon 1

H指数:33

被引数:2,910

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Motivations and Behavioural Intentions of French Boxing Leaders: Exploring Gender and Retention Factors

法国拳击领导者的动机和行为意图：探究性别和留存因素

JOURNAL OF COMMUNITY & APPLIED SOCIAL PSYCHOLOGY

IF2.1

2026-03-180

PRE

Exploiting Co(III)-Cyclopentadienyl Complexes To Develop Anticancer Agents

INORGANIC CHEMISTRY

IF4.7

2024-03-197

OA

Dual FGFR-targeting and pH-activatable ruthenium-peptide conjugates for targeted therapy of breast cancer

DALTON TRANSACTIONS

IF3.3

2024-01-011

OA

Iron(II)-cyclopentadienyl compounds are cytotoxic against colon adenocarcinoma cell lines: Ethylenebis(diphenylphosphane) vs. triphenylphosphane

JOURNAL OF INORGANIC BIOCHEMISTRY

IF3.2

2023-12-012

OAAI

Novel family of [RuCp(N,N)(P)] plus compounds with simultaneous anticancer and antibacterial activity: Biological evaluation and solution chemistry studies

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2023-12-013

OAAI

Fighting Multidrug Resistance with Ruthenium-Cyclopentadienyl Compounds: Unveiling the Mechanism of P-gp Inhibition

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2023-08-244

OAAI

First iron(II) organometallic compound acting as ABCB1 inhibitor

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2023-08-016

OAAI

Design and Anticancer Properties of New Water-Soluble Ruthenium-Cyclopentadienyl Complexes

PHARMACEUTICALS

IF4.8

2022-07-1411

OAAI

Biotinylated Polymer-Ruthenium Conjugates: In Vitro and In Vivo Studies in a Triple-Negative Breast Cancer Model

IF5.5

2022-06-3012

OAAI

Binding of RuCp complexes with human apo-transferrin: fluorescence spectroscopy and molecular docking methods

IF3.6

2021-06-227

PREAI

Unprecedented collateral sensitivity for cisplatin-resistant lung cancer cells presented by new ruthenium organometallic compounds

INORGANIC CHEMISTRY FRONTIERS

IF6.4

2021-01-0123

OAAI

Cu(I) complexes as new antiproliferative agents against sensitive and doxorubicin resistant colorectal cancer cells: synthesis, characterization, and mechanisms of action

DALTON TRANSACTIONS

IF3.3

2021-01-0119

PREAI

A New Family of Iron(II)-Cyclopentadienyl Compounds Shows Strong Activity against Colorectal and Triple Negative Breast Cancer Cells

IF4.6

2020-03-3026

OAAI

Novel ruthenium cyclopentadienyl - peptide conjugate complexes against human FGFR(+) breast cancer

DALTON TRANSACTIONS

IF3.3

2020-01-0116

PREAI

New copper(i) complexes selective for prostate cancer cells

DALTON TRANSACTIONS

IF3.3

2020-01-0114

PREAI

May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2019-08-0138

PREAI

Ruthenium-Cyclopentadienyl Bipyridine-Biotin Based Compounds: Synthesis and Biological Effect

INORGANIC CHEMISTRY

IF4.7

2019-06-2637

OAAI

Polymer ruthenium-cyclopentadienyl conjugates - New emerging anti-cancer drugs

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2019-04-0128

OAAI

Unprecedented inhibition of P-gp activity by a novel ruthenium-cyclopentadienyl compound bearing a bipyridine-biotin ligand

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2019-02-0143

OAAI

Methyl-cyclopentadienyl Ruthenium Compounds with 2,2′-Bipyridine Derivatives Display Strong Anticancer Activity and Multidrug Resistance Potential

INORGANIC CHEMISTRY

IF4.7

2018-04-0333

OAAI